课题基金 / 基金详情

Gut-peptide based polypharmacy for the treatment of obesity and anxiodepressive behavior: the role of astrocytes

Gut-peptide based polypharmacy for the treatment of obesity and anxiodepressive behavior: the role of astrocytes
基于肠肽的多药治疗肥胖和抗氧化抑郁行为：星形胶质细胞的作用
批准号：
362255
负责人：
Fisette Alexandre
金额：
$10.93万
依托单位：
Helmholtz Center Munich (Germany)
依托单位国家：
加拿大
项目类别：
Fellowship Programs
财政年份：
2016
资助国家：
加拿大
项目状态：
已结题
起止时间：
2016-11-01 至 2019-11-01
来源：
https://webapps.cihr-irsc.gc.ca/decisions/p/project_details.html?applId=362255&lang=en
关键词：
Anxio-Depressive Behavior Dexamethasone Dreadd Feeding Behavior Glp-1 Metabolic Syndrome Neuroinflammation Polypharmacy Type 2 Diabetes

项目摘要

项目成果

Fisette Alexandre的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Obesity and high-fat regimen lead to brain functions impairment such as altered feeding behavior and development of anxiety- and depressive-like behavior. There is a strong link between obesity and depression in humans and animals alike and high-fat diet-
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Characterization of a novel molecular strategy to alleviate post-menopausal metabolic & mood disorders
海外基金